World's Best Scientists 2026 revealed!
Alzheimer's and Dementia: Translational Research and Clinical Interventions
H-index 36

Alzheimer's and Dementia: Translational Research and Clinical Interventions

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Neuroscience 85 197 186 29
Medicine 604 296 243 31

Additional Metrics

Number of Best Scientists*: 588
Documents by Best Scientists*: 346
Top 100 Ranked Scientists*: 35
SCIMAGO H-index: 66
SCIMAGO SJR: 2.146
Impact Factor: 6.8

Overview

Top Research Topics at Alzheimer's & Dementia: Translational Research & Clinical Interventions?

Alzheimer's & Dementia: Translational Research & Clinical Interventions explores disciplines such as Dementia, Disease, Cognition, Internal medicine and Clinical trial. Alzheimer's & Dementia: Translational Research & Clinical Interventions focuses on Dementia but the discussions also offer insight into other areas such as Psychological intervention, Psychiatry, Gerontology, Randomized controlled trial and Clinical psychology. It investigates Randomized controlled trial research which frequently intersects with Physical therapy.

Alzheimer's & Dementia: Translational Research & Clinical Interventions explores topics in Disease which can be helpful for research in disciplines like Biomarker (medicine), Drug development and Neuroimaging. The research on Cognition featured in it combines topics in other fields like Intervention (counseling), Physical medicine and rehabilitation, Cohort and Cognitive decline. Internal medicine research featured in the journal incorporates concerns from various other topics such as Placebo, Oncology and Endocrinology.

The journal links adjacent topics like Placebo with Tolerability. It focuses on Clinical trial research which is adjacent to topics in Intensive care medicine.

  • Dementia (44.99%)
  • Disease (40.67%)
  • Cognition (25.93%)

What are the most cited papers published in the journal?

  • Inflammation as a central mechanism in Alzheimer's disease (493 citations)
  • Alzheimer's disease drug development pipeline: 2018. (432 citations)
  • Alzheimer's disease drug development pipeline: 2019. (311 citations)

Research areas of the most cited articles at Alzheimer's & Dementia: Translational Research & Clinical Interventions:

The main points discussed in the most cited papers deal with Disease, Dementia, Clinical trial, Internal medicine and Cognition. The most cited publications focus on Disease but the discussions also offer insight into other areas such as Psychiatry, Activities of daily living and Gerontology. The works on Clinical trial tackled in the published articles bring together disciplines like Biomarker (medicine), Solanezumab, Drug development and Intensive care medicine.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Gene

The previous edition focused in particular on these issues:

The journal facilitates discussions on Dementia, Disease, Internal medicine, Cognition and Cognitive decline. While Dementia is the focus of Alzheimer's & Dementia: Translational Research & Clinical Interventions, it also provided insights into the studies of Logistic regression, Clinical trial, Gerontology, Clinical psychology and Hazard ratio. Topics in Disease were tackled in line with various other fields like Endocrinology and Cohort study.

The studies in Internal medicine featured incorporate elements of Placebo and Oncology. Issues in Cognition were discussed, taking into consideration concepts from other disciplines like Weight loss, Elderly persons, Epidemiology and Physical medicine and rehabilitation. It explores research in Randomized controlled trial and overlapping concepts in Cognitive training, Physical therapy and Intervention (counseling) to expand the discourse in Cognitive decline.

The most cited articles from the last journal are:

  • Alzheimer's disease drug development pipeline: 2021. (8 citations)
  • Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease. (8 citations)
  • Donanemab (LY3002813) dose‐escalation study in Alzheimer's disease (6 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Alzheimer's & Dementia: Translational Research & Clinical Interventions (based on the number of publications) are:

  • Jeffrey L. Cummings (21 papers) published 4 papers at the last edition, 2 more than at the previous edition,
  • Maria C. Carrillo (11 papers) published 2 papers at the last edition, 2 less than at the previous edition,
  • Serge Gauthier (11 papers) published 1 paper at the last edition, 6 less than at the previous edition,
  • Craig W. Ritchie (10 papers) absent at the last edition,
  • Lisa J. Bain (10 papers) published 1 paper at the last edition, 3 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Alzheimer's & Dementia: Translational Research & Clinical Interventions (based on the number of publications) are:

  • University of California, San Francisco (33 papers) published 8 papers at the last edition, 4 less than at the previous edition,
  • University of California, San Diego (25 papers) published 2 papers at the last edition, 2 less than at the previous edition,
  • Harvard University (24 papers) published 5 papers at the last edition the same number as at the previous edition,
  • Lou Ruvo Brain Institute (23 papers) published 3 papers at the last edition, 1 less than at the previous edition,
  • University of Southern California (21 papers) published 4 papers at the last edition, 2 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.12% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 29.55% were posted by at least one author from the top 10 institutions publishing in the journal. Another 18.18% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 21.59% of all publications and 30.68% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Relevance for Professionals in the Medical Field

Given the complex nature of Alzheimer's and Dementia research, individuals from diverse medical disciplines can find valuable insights from the pages of Alzheimer's & Dementia: Translational Research & Clinical Interventions. For instance, speech and language pathologists working with patients exhibiting cognitive decline or Alzheimer's disease can gain from incorporating the latest research into their therapeutic practice.

As a detailed example, those who wish to pursue a career as a speech pathologist, particularly in locations such as Kansas, may need to fulfill specific requirements and qualifications. For further information, you may want to visit this informative page on speech pathologist requirements in Kansas. Through the assimilation of new knowledge from research on Alzheimer's and dementia, speech pathologists can better serve their patients by adopting innovative therapeutic methods and approaches based on up-to-date scientific evidence.

Whether you are an aspiring or practicing medical professional, engaging with the latest scientific discourse in your field presents a unique opportunity to further advance your career and the quality of care provided to your patients.

Top Publications

  • Alzheimer's disease drug development pipeline: 2020.

    Jeffrey Cummings;Jeffrey Cummings;Garam Lee;Aaron Ritter;Marwan Sabbagh

    (2020)
    486 Citations
  • Alzheimer's disease drug development pipeline: 2021.

    Jeffrey Cummings;Garam Lee;Kate Zhong;Jorge Fonseca

    (2021)
    331 Citations
  • Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers

    (2022)
    145 Citations
  • Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019

    (2021)
    91 Citations
  • Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites

    (2022)
    89 Citations
  • Health status and risk profiles for brain aging of rural‐dwelling older adults: Data from the interdisciplinary baseline assessments in MIND‐China

    (2022)
    84 Citations
  • Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank.

    Michael P. Vitek;Joseph A. Araujo;Michael Fossel;Barry D. Greenberg

    (2020)
    83 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their medical careers beyond studying Medicine in the USA, pursuing online degrees in nursing offers accessible and flexible options. Many students seek affordable education options, which is why exploring an online nursing degree can be a smart first step. These programs provide essential training to enter the healthcare field quickly.

Advancing within nursing, a cheapest DNP program allows registered nurses to earn a Doctor of Nursing Practice degree online, paving the way for leadership roles and specialized clinical practice without the high costs typically associated with doctoral studies.

For working nurses aiming to upgrade their qualifications, consider the cheapest RN to BSN online programs, which offer flexible pathways to earn a Bachelor of Science in Nursing degree. These programs often accommodate busy schedules while enhancing career opportunities.

Additionally, some students may prefer nursing colleges that offer simplified admissions. Exploring nursing colleges that don’t require SAT exams or standardized entrance tests can reduce barriers and streamline the application process.

Best Scientists Contributing to This Journal